Inhibition of p38 mitogen‐activated protein kinase signaling reduces multidrug transporter activity and anti‐epileptic drug resistance in refractory epileptic rats
- 21 January 2016
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 136 (5) , 1096-1105
Abstract
It is widely recognized that P‐glycoprotein (P‐gp) mediates drug resistance in refractory epilepsy. However, the molecular mechanism underlying the up‐regulation of P‐gp expression remains unclear. Our previous studies have demonstrated that p38 mitogen‐activated protein kinase (MAPK) regulates P‐gp expression in cultured K562 cells. However, a lack of in vivo research leaves unanswered questions regarding whether p38MAPK regulates P‐gp expression or drug resistance in refractory epilepsy. This in vivo study examined the effects of p38MAPK on the expression of P‐gp and mdr1 in the rat brain and quantified antiepileptic drug (AED) concentrations in the hippocampal extracellular fluid. In addition, the role of p38MAPK in electrical and behavioral activity in a rat epilepsy model was studied. The results indicated that p38MAPK inhibition by SB202190 reduced P‐gp expression, while increasing AED concentration in the hippocampal extracellular fluid in refractory epileptic rats. SB202190 also reduced the resistance to AEDs in drug‐resistant rats and significantly reduced the severity of seizure activity. These results suggest that p38MAPK could participate in drug resistance in refractory epilepsy through the regulation of P‐gp. image We show that the specific inhibitor of p38MAPK could down‐regulate the expression of multidrug transporter (P‐glycoprotein) in blood–brain barrier, increase the concentration of antiepileptic drugs in the hippocampal extracellular fluid and reduce anti‐epileptic drug resistance in refractory epileptic rats. We propose that the p38MAPK signaling pathway participates in drug resistance in refractory epilepsy through the regulation of P‐glycoprotein expression.Keywords
Funding Information
- National Natural Science Foundation of China (81571261)
- Natural Science Foundation of Shanghai Municipality (09ZR1405500)
This publication has 44 references indexed in Scilit:
- A p38MAPK/MK2 signaling pathway leading to redox stress, cell death and ischemia/reperfusion injuryCell Communication and Signaling, 2014
- The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer's diseaseFrontiers in Physiology, 2013
- Dual regulation of P-glycoprotein expression by Trichostatin A in cancer cell linesBMC Molecular Biology, 2012
- Heat shock factor-1 knockout induces multidrug resistance gene, MDR1b, and enhances P-glycoprotein (ABCB1)-based drug extrusion in the heartProceedings of the National Academy of Sciences, 2012
- Inhibition of p38 MAPK diminishes doxorubicin-induced drug resistance associated with P-glycoprotein in human leukemia K562 cellsMedical Science Monitor, 2012
- Association between temporal lobe P-glycoprotein expression and seizure recurrence after surgery for pharmacoresistant temporal lobe epilepsyNeurobiology of Disease, 2010
- COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic ratsNeuropharmacology, 2010
- Acidosis induces multi‐drug resistance in rat prostate cancer cells (AT1) in vitro and in vivo by increasing the activity of the p‐glycoprotein via activation of p38International Journal of Cancer, 2008
- ABC Transporters during Epilepsy and Mechanisms Underlying Multidrug Resistance in Refractory EpilepsyEpilepsia, 2007
- NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cellsOncogene, 2003